Leanne Kelly

Insider Reports History

Entity
Individual
Location
C/O Vallon Pharamceuticals, Inc., 100 N 18 Th Street, Suite 300, Philadelphia, PA
Signature
/s/ Leanne Kelly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leanne Kelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GRI BIO, Inc. Chief Financial Officer Stock Option (Right to Buy) 83.3K $127K $1.52 Sep 22, 2023 Direct

Insider Reports Filed by Leanne Kelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GRI GRI BIO, Inc. Sep 22, 2023 1 $127K 4 Sep 26, 2023 Chief Financial Officer
GRI Vallon Pharmaceuticals, Inc. Feb 15, 2022 1 $282K 4 Mar 1, 2022 Chief Financial Officer
GRI Vallon Pharmaceuticals, Inc. Jun 2, 2021 3 $25.2K 4 Jun 4, 2021 Chief Financial Officer
GRI Vallon Pharmaceuticals, Inc. May 14, 2021 1 $0 4 May 18, 2021 Chief Financial Officer
GRI Vallon Pharmaceuticals, Inc. May 11, 2021 0 $0 3 May 18, 2021 Chief Financial Officer